Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.50% | 19.56% | -115.06% | 26.93% | -109.55% |
| Total Depreciation and Amortization | 0.00% | 71.76% | 71.47% | 46.57% | 73.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.35% | -46.19% | 668.40% | -65.37% | 144.36% |
| Change in Net Operating Assets | 330.45% | 16,710.00% | 59.46% | -202.45% | -120.20% |
| Cash from Operations | -3.63% | 18.59% | -5.04% | -52.95% | -20.95% |
| Capital Expenditure | -591.12% | -1,106.90% | -82.72% | -1,179.17% | 18.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -604.29% | -1,106.90% | -82.72% | -1,179.17% | -303.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -336.59% | -39.53% | -245.45% | -- | -173.33% |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 86.36% | 100.00% | 100.00% | -- | -- |
| Cash from Financing | -102.33% | 52.94% | -101.16% | -- | 36,223.33% |
| Foreign Exchange rate Adjustments | -400.00% | -400.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -238.27% | 1.97% | -283.31% | 681.03% | 221.19% |